Literature DB >> 19779318

Orally exposed uninfected individuals have systemic anti-HIV responses associating with partners' viral load.

Klara Hasselrot1, Göran Bratt, Taha Hirbod, Pär Säberg, Mariethe Ehnlund, Lucia Lopalco, Eric Sandström, Kristina Broliden.   

Abstract

OBJECTIVES: To determine whether oral HIV-1 exposure incites a persistent systemic anti-HIV-1 response in exposed uninfected individuals of discordant couples of men who have sex with men, and whether this response associates with HIV-1 exposure measured by viral load in the HIV-positive partners.
METHODS: Plasma were collected from exposed uninfected individuals (n = 25), HIV-positive partners (n = 25) and low-risk controls (n = 22). A peripheral blood mononuclear cells-based neutralization assay was used to test these samples against three primary HIV-1 isolates. Self-reported questionnaires described routes of HIV-1-exposure, and clinical records documented viral loads in HIV-positive partners.
RESULTS: At enrollment, plasma samples from seven of 25 exposed uninfected individuals neutralized at least two of the three HIV-1 isolates. No samples from the 22 controls neutralized any HIV-1 isolate (P = 0.01). Of these seven exposed uninfected individuals, six retained neutralization capacity during follow-up. Neutralization capacity among exposed uninfected individuals associated with the highest measured viral load of their respective partners (P = 0.01) and also time since highest viral load (P = 0.02). Purified plasma immunoglobulin (Ig) A1-mediated neutralization was observed in six of the seven samples, whereas none of the IgA1-depleted plasma samples neutralized HIV-1. The neutralizing IgA1 was not HIV envelope specific as detected by ELISA and western blot.
CONCLUSION: Orally exposed uninfected men who have sex with men can mount neutralizing anti HIV-1 activity in plasma, mediated primarily by non-HIV envelope-specific IgA1. Neutralization was associated with previous measured highest viral load in the HIV-positive partner, as well as time elapsed since the peak viral load. Neutralization also persisted over time in spite of a continuous low viral exposure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19779318     DOI: 10.1097/QAD.0b013e3283329853

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  8 in total

1.  GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates.

Authors:  Emma L Mohr; Jinhua Xiang; James H McLinden; Thomas M Kaufman; Qing Chang; David C Montefiori; Donna Klinzman; Jack T Stapleton
Journal:  J Immunol       Date:  2010-09-08       Impact factor: 5.422

2.  Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccinees.

Authors:  Charlotta Nilsson; Karina Godoy-Ramirez; Bo Hejdeman; Andreas Bråve; Lindvi Gudmundsdotter; David Hallengärd; Jeffrey R Currier; Lindsay Wieczorek; Klara Hasselrot; Patricia L Earl; Victoria R Polonis; Mary A Marovich; Merlin L Robb; Eric Sandström; Britta Wahren; Gunnel Biberfeld
Journal:  AIDS Res Hum Retroviruses       Date:  2013-11-15       Impact factor: 2.205

3.  Immune approaches for the prevention of breast milk transmission of HIV-1.

Authors:  Barbara Lohman-Payne; Jennifer Slyker; Sarah L Rowland-Jones
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

4.  Genetic and Immunological Factors Involved in Natural Resistance to HIV-1 Infection.

Authors:  Natalia Taborda-Vanegas; Wildeman Zapata; María Teresa Rugeles
Journal:  Open Virol J       Date:  2011-05-11

5.  Antiviral factors and type I/III interferon expression associated with regulatory factors in the oral epithelial cells from HIV-1-serodiscordant couples.

Authors:  Cesar A C Cervantes; Luanda M S Oliveira; Kelly C G Manfrere; Josenilson F Lima; Natalli Z Pereira; Alberto J S Duarte; Maria N Sato
Journal:  Sci Rep       Date:  2016-05-11       Impact factor: 4.379

6.  Sexual role and HIV-1 set point viral load among men who have sex with men.

Authors:  Sarah E Stansfield; John E Mittler; Geoffrey S Gottlieb; James T Murphy; Deven T Hamilton; Roger Detels; Steven M Wolinsky; Lisa P Jacobson; Joseph B Margolick; Charles R Rinaldo; Joshua T Herbeck; Steven M Goodreau
Journal:  Epidemics       Date:  2018-08-30       Impact factor: 4.396

Review 7.  Functional avidity: a measure to predict the efficacy of effector T cells?

Authors:  Selena Viganò; Daniel T Utzschneider; Matthieu Perreau; Giuseppe Pantaleo; Dietmar Zehn; Alexandre Harari
Journal:  Clin Dev Immunol       Date:  2012-11-20

8.  A comparative proteomic analysis of the soluble immune factor environment of rectal and oral mucosa.

Authors:  Laura M Romas; Klara Hasselrot; Lindsay G Aboud; Kenzie D Birse; T Blake Ball; Kristina Broliden; Adam D Burgener
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.